Participants were identified either prospectively or retrospectively via chart ... bupropion. Stimulant medication use was permitted if deemed low risk by a physician co-investigator (which applied to ...

The benefits of naltrexone/bupropion (Mysimba) continue to outweigh its risks, despite ongoing uncertainty about long-term ...

Wellbutrin is the brand name for the antidepressant drug bupropion. The Food and Drug Administration (FDA) approved Wellbutrin in the United States for treating depression in 1985. They approved ...

Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...

Texas, New York, California, and Florida, have confirmed measles cases. There are 70% more cases in 2025 so far than in all ...

Answering these questions requires a quick bit of background information. Bupropion is approved by the U.S. Food and Drug Administration (FDA) for depression, seasonal affective disorder and ...

Despite their established effectiveness, uptake of the WHO best buys for tackling non-communicable diseases (NCDs) has been ...

or older weight loss drug bupropion-naltrexone, or Contrave. Overall, semaglutide users were found to be 52 percent more likely to lose their hair while on the drug compared to those who took the ...

Mass layoffs began Tuesday at the Centers for Disease Control and Prevention and at the Food and Drug Administration, the first steps in a plan to cut 10,000 jobs at the Department of Health and Human ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...

Here’s a look at 23andMe’s rise and fall in four charts. Just months after it started ... GSK “to gather insights and discover novel drug targets driving disease progression and develop ...